Sorry, you need to enable JavaScript to visit this website.

PRISTIQ (desvenlafaxine succinate) Health Professional Information

Pfizer recognizes the public concern in relation to COVID-19, which continues to evolve. Click here to learn how we are responding.
Pfizer reconnaît les préoccupations du grand public concernant la situation liée à la COVID-19, qui continue d'évoluer. Cliquez ici pour savoir comment nous avons réagi.

Health Professional Information

SUMMARY PRODUCT INFORMATION

Route of AdministrationDosage Form / StrengthNonmedicinal Ingredients
OralPRISTIQ: extended-release tablet (50 and 100 mg desvenlafaxine as desvenlafaxine succinate)hypromellose, magnesium stearate, microcrystalline cellulose, talc, and film coating (which consists of polyvinyl alcohol, titanium dioxide, polyethylene glycol, talc, iron oxides, and sunset yellow aluminum lake)

What's New

No Current Announcements.

Contact Pfizer Medical Information

Report an Adverse Event
1 866 723-7111